- Home
- Publications
- Publication Search
- Publication Details
Title
Clinically Applicable Inhibitors Impacting Genome Stability
Authors
Keywords
-
Journal
MOLECULES
Volume 23, Issue 5, Pages 1166
Publisher
MDPI AG
Online
2018-05-14
DOI
10.3390/molecules23051166
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting Epigenetics in Cancer
- (2018) Richard L. Bennett et al. Annual Review of Pharmacology and Toxicology
- Streptonigrin Inhibits SENP1 and Reduces the Protein Level of Hypoxia-Inducible Factor 1α (HIF1α) in Cells
- (2018) Nigus Ambaye et al. BIOCHEMISTRY
- Discovery of potent DOT1L inhibitors by AlphaLISA based High Throughput Screening assay
- (2018) Yakai Song et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Human RecQL4 helicase plays multifaceted roles in the genomic stability of normal and cancer cells
- (2018) Dongliang Mo et al. CANCER LETTERS
- Once and only once: mechanisms of centriole duplication and their deregulation in disease
- (2018) Erich A. Nigg et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- MRN complex-dependent recruitment of ubiquitylated BLM helicase to DSBs negatively regulates DNA repair pathways
- (2018) Vivek Tripathi et al. Nature Communications
- Directing the use of DDR kinase inhibitors in cancer treatment
- (2017) Inger Brandsma et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Loss of E-cadherin provides tolerance to centrosome amplification in epithelial cancer cells
- (2017) Alexander D. Rhys et al. JOURNAL OF CELL BIOLOGY
- Molecular mechanisms of kinesin-14 motors in spindle assembly and chromosome segregation
- (2017) Zhen-Yu She et al. JOURNAL OF CELL SCIENCE
- The Search for Potent, Small-Molecule HDACIs in Cancer Treatment: A Decade After Vorinostat
- (2017) Chiara Zagni et al. MEDICINAL RESEARCH REVIEWS
- Rad52 Inverse Strand Exchange Drives RNA-Templated DNA Double-Strand Break Repair
- (2017) Olga M. Mazina et al. MOLECULAR CELL
- ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response
- (2017) Andrew N. Blackford et al. MOLECULAR CELL
- Histone methylation and the DNA damage response
- (2017) Fade Gong et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- The multifaceted roles of PARP1 in DNA repair and chromatin remodelling
- (2017) Arnab Ray Chaudhuri et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The cancer epigenome: Concepts, challenges, and therapeutic opportunities
- (2017) Mark A. Dawson SCIENCE
- PARP inhibitors: Synthetic lethality in the clinic
- (2017) Christopher J. Lord et al. SCIENCE
- Chidamide in the treatment of peripheral T-cell lymphoma
- (2017) Thomas Chan et al. OncoTargets and Therapy
- A comprehensive review of lysine-specific demethylase 1 and its roles in cancer
- (2017) Amir Hosseini et al. Epigenomics
- Stat3 regulates centrosome clustering in cancer cells via Stathmin/PLK1
- (2017) Edward J. Morris et al. Nature Communications
- Oncogenic PIK3CA induces centrosome amplification and tolerance to genome doubling
- (2017) Inma M. Berenjeno et al. Nature Communications
- Reversion Mutations with Clinical Use of PARP Inhibitors: Many Genes, Many Versions
- (2017) Susan M. Domchek Cancer Discovery
- Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
- (2017) Chantal Pauli et al. Cancer Discovery
- Poly-(ADP-ribose)-polymerase inhibitors as radiosensitizers: a systematic review of pre-clinical and clinical human studies
- (2017) Paul Lesueur et al. Oncotarget
- Inhibition of polo-like kinase 4 (PLK4): a new therapeutic option for rhabdoid tumors and pediatric medulloblastoma
- (2017) Simone Treiger Sredni et al. Oncotarget
- Exclusive destruction of mitotic spindles in human cancer cells
- (2017) Leonid Visochek et al. Oncotarget
- Advances in Precision Medicine: Tailoring Individualized Therapies
- (2017) Kyle Matchett et al. Cancers
- Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer
- (2017) Peter McAnena et al. Cancers
- Preclinical characterization of the selective DNA-dependent protein kinase (DNA-PK) inhibitor VX-984 in combination with chemotherapy
- (2016) D. Boucher et al. ANNALS OF ONCOLOGY
- Novel Insights into the Roles of Rho Kinase in Cancer
- (2016) Lei Wei et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Targeting cancer using KAT inhibitors to mimic lethal knockouts
- (2016) J. A. L. Brown et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Synthesis and activity of benzimidazole-1,3-dioxide inhibitors of separase
- (2016) Ha T. Do et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Pharmacological Inhibition of Centrosome Clustering by Slingshot-Mediated Cofilin Activation and Actin Cortex Destabilization
- (2016) Gleb Konotop et al. CANCER RESEARCH
- Abstract 1658: M3814, a novel investigational DNA-PK inhibitor: enhancing the effect of fractionated radiotherapy leading to complete regression of tumors in mice
- (2016) Frank T. Zenke et al. CANCER RESEARCH
- Big Data–Led Cancer Research, Application, and Insights
- (2016) James A.L. Brown et al. CANCER RESEARCH
- Targeting NEK2 as a promising therapeutic approach for cancer treatment
- (2016) Yanfen Fang et al. CELL CYCLE
- RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer
- (2016) Yajing Liu et al. CLINICAL CANCER RESEARCH
- SCR7 is neither a selective nor a potent inhibitor of human DNA ligase IV
- (2016) George E. Greco et al. DNA REPAIR
- Identifying high quality, potent and selective inhibitors of ATM kinase: Discovery of AZD0156
- (2016) B. Barlaam et al. EUROPEAN JOURNAL OF CANCER
- Recent findings and future directions for interpolar mitotic kinesin inhibitors in cancer therapy
- (2016) Stephanie M Myers et al. Future Medicinal Chemistry
- WRN-targeted therapy using inhibitors NSC 19630 and NSC 617145 induce apoptosis in HTLV-1-transformed adult T-cell leukemia cells
- (2016) R. Moles et al. Journal of Hematology & Oncology
- KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases
- (2016) Roman P. Simon et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel 3-Quinoline Carboxamides as Potent, Selective, and Orally Bioavailable Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase
- (2016) Sébastien L. Degorce et al. JOURNAL OF MEDICINAL CHEMISTRY
- Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics
- (2016) Rosie Elizabeth Ann Gutteridge et al. MOLECULAR CANCER THERAPEUTICS
- The TIP60 Complex Regulates Bivalent Chromatin Recognition by 53BP1 through Direct H4K20me Binding and H2AK15 Acetylation
- (2016) Karine Jacquet et al. MOLECULAR CELL
- The molecular hallmarks of epigenetic control
- (2016) C. David Allis et al. NATURE REVIEWS GENETICS
- Targeting BRCA1- and BRCA2-deficient cells with RAD52 small molecule inhibitors
- (2016) Fei Huang et al. NUCLEIC ACIDS RESEARCH
- DNA repair targeted therapy: The past or future of cancer treatment?
- (2016) Navnath S. Gavande et al. PHARMACOLOGY & THERAPEUTICS
- Identification of a Small Molecule Inhibitor of RAD52 by Structure-Based Selection
- (2016) Katherine Sullivan et al. PLoS One
- Targeting the kinase activities of ATR and ATM exhibits antitumoral activity in mouse models ofMLL-rearranged AML
- (2016) Isabel Morgado-Palacin et al. Science Signaling
- Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action
- (2016) Y. Pommier et al. Science Translational Medicine
- Regulation of Single-Strand Annealing and its Role in Genome Maintenance
- (2016) Ragini Bhargava et al. TRENDS IN GENETICS
- Insights into APC/C: from cellular function to diseases and therapeutics
- (2016) Zhuan Zhou et al. Cell Division
- Turning a Substrate Peptide into a Potent Inhibitor for the Histone Methyltransferase SETD8
- (2016) Russell A. Judge et al. ACS Medicinal Chemistry Letters
- TCPs: privileged scaffolds for identifying potent LSD1 inhibitors for cancer therapy
- (2016) Yi-Chao Zheng et al. Epigenomics
- A CEP215–HSET complex links centrosomes with spindle poles and drives centrosome clustering in cancer
- (2016) Pavithra L. Chavali et al. Nature Communications
- Histone acetyltransferase inhibitor CPTH6 preferentially targets lung cancer stem-like cells
- (2016) Marta Di Martile et al. Oncotarget
- KIFC1: a promising chemotherapy target for cancer treatment?
- (2016) Yu-Xi Xiao et al. Oncotarget
- “Back to a false normality”: new intriguing mechanisms of resistance to PARP inhibitors
- (2016) Lorena Incorvaia et al. Oncotarget
- Activity of the novel polo-like kinase 4 inhibitor CFI-400945 in pancreatic cancer patient-derived xenografts
- (2016) Ines Lohse et al. Oncotarget
- MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells
- (2016) Kathleen A. Bridges et al. Oncotarget
- Acetylation Reader Proteins: Linking Acetylation Signaling to Genome Maintenance and Cancer
- (2016) Fade Gong et al. PLoS Genetics
- Predictors and Modulators of Synthetic Lethality: An Update on PARP Inhibitors and Personalized Medicine
- (2016) Stephen Murata et al. Biomed Research International
- Small-molecule inhibitors identify the RAD52-ssDNA interaction as critical for recovery from replication stress and for survival of BRCA2 deficient cells
- (2016) Sarah R Hengel et al. eLife
- Targeting the kinase activities of ATR and ATM exhibits antitumoral activity in mouse models ofMLL-rearranged AML
- (2016) Isabel Morgado-Palacin et al. Science Signaling
- Targeting DNA Replication Stress for Cancer Therapy
- (2016) Jun Zhang et al. Genes
- RecQ helicases and PARP1 team up in maintaining genome integrity
- (2015) Sebastian Veith et al. AGEING RESEARCH REVIEWS
- Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma
- (2015) Y. Shi et al. ANNALS OF ONCOLOGY
- Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering
- (2015) Jeffrey W. Johannes et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Genome-Wide Identification and Characterization of Novel Factors Conferring Resistance to Topoisomerase II Poisons in Cancer
- (2015) R. H. Wijdeven et al. CANCER RESEARCH
- Small-Molecule Disruption of RAD52 Rings as a Mechanism for Precision Medicine in BRCA-Deficient Cancers
- (2015) Gurushankar Chandramouly et al. CHEMISTRY & BIOLOGY
- DNA Double-Strand Break Repair Inhibitors as Cancer Therapeutics
- (2015) Mrinal Srivastava et al. CHEMISTRY & BIOLOGY
- Centrosomes are multifunctional regulators of genome stability
- (2015) Dorothy A. Lerit et al. CHROMOSOME RESEARCH
- FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma
- (2015) H.-Z. Lee et al. CLINICAL CANCER RESEARCH
- Chromatin perturbations during the DNA damage response in higher eukaryotes
- (2015) Christopher J. Bakkenist et al. DNA REPAIR
- Inhibition of the ERCC1–XPF structure-specific endonuclease to overcome cancer chemoresistance
- (2015) Ewan M. McNeil et al. DNA REPAIR
- Synthesis, molecular modeling, and biological evaluation of novel RAD51 inhibitors
- (2015) Jiewen Zhu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Drugging ATR: progress in the development of specific inhibitors for the treatment of cancer
- (2015) Kevin M Foote et al. Future Medicinal Chemistry
- Hsp72 is targeted to the mitotic spindle by Nek6 to promote K-fiber assembly and mitotic progression
- (2015) Laura O’Regan et al. JOURNAL OF CELL BIOLOGY
- Synthetic lethality in chronic lymphocytic leukaemia with DNA damage response defects by targeting the ATR pathway
- (2015) Marwan Kwok et al. LANCET
- Mitoxantrone, More than Just Another Topoisomerase II Poison
- (2015) Benny J. Evison et al. MEDICINAL RESEARCH REVIEWS
- Targeting the DNA Damage Response in Cancer
- (2015) Mark J. O’Connor MOLECULAR CELL
- Transient PLK4 overexpression accelerates tumorigenesis in p53-deficient epidermis
- (2015) Özdemirhan Serçin et al. NATURE CELL BIOLOGY
- Centrosome function and assembly in animal cells
- (2015) Paul T. Conduit et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- KATs in cancer: functions and therapies
- (2015) A Farria et al. ONCOGENE
- Taking aim at a dynamic target: Noscapinoids as microtubule-targeted cancer therapeutics
- (2015) Manu Lopus et al. Pharmacological Reports
- Targeting Cdc20 as a novel cancer therapeutic strategy
- (2015) Lixia Wang et al. PHARMACOLOGY & THERAPEUTICS
- ATM and ATR as therapeutic targets in cancer
- (2015) Anika Maria Weber et al. PHARMACOLOGY & THERAPEUTICS
- The DNA-dependent protein kinase: A multifunctional protein kinase with roles in DNA double strand break repair and mitosis
- (2015) Nicholas Jette et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- PLK1 regulation of PCNT cleavage ensures fidelity of centriole separation during mitotic exit
- (2015) Jaeyoun Kim et al. Nature Communications
- Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma
- (2015) M. R. Girotti et al. Cancer Discovery
- Co-inhibition of polo-like kinase 1 and Aurora kinases promotes mitotic catastrophe
- (2015) Jingjing Li et al. Oncotarget
- Over-expression of Plk4 induces centrosome amplification, loss of primary cilia and associated tissue hyperplasia in the mouse
- (2015) Paula A. Coelho et al. Open Biology
- DNA Damage Response Factors from Diverse Pathways, Including DNA Crosslink Repair, Mediate Alternative End Joining
- (2015) Sean M. Howard et al. PLoS Genetics
- PLK-1 Targeted Inhibitors and Their Potential against Tumorigenesis
- (2015) Shiv Kumar et al. Biomed Research International
- Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo
- (2015) J M Gajer et al. Oncogenesis
- Aurora Kinase Inhibitors: Current Status and Outlook
- (2015) Vassilios Bavetsias et al. Frontiers in Oncology
- Identification of novel small molecule inhibitors of centrosome clustering in cancer cells
- (2015) Eiko Kawamura et al. Oncotarget
- Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970
- (2015) Amy B. Hall et al. Oncotarget
- Delivering precision medicine in oncology today and in future—the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO)
- (2014) F. Ciardiello et al. ANNALS OF ONCOLOGY
- Human RecQ Helicases in DNA Repair, Recombination, and Replication
- (2014) Deborah L. Croteau et al. Annual Review of Biochemistry
- Polo-like Kinase 4 Inhibition: A Strategy for Cancer Therapy?
- (2014) Andrew J. Holland et al. CANCER CELL
- Functional Characterization of CFI-400945, a Polo-like Kinase 4 Inhibitor, as a Potential Anticancer Agent
- (2014) Jacqueline M. Mason et al. CANCER CELL
- Phase 1 dose-escalation study of the PARP inhibitor CEP-9722 as monotherapy or in combination with temozolomide in patients with solid tumors
- (2014) Ruth Plummer et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The RAD51-Stimulatory Compound RS-1 Can Exploit the RAD51 Overexpression That Exists in Cancer Cells and Tumors
- (2014) J. M. Mason et al. CANCER RESEARCH
- Partial inhibition of Cdk1 in G2phase overrides the SAC and decouples mitotic events
- (2014) Rachael A McCloy et al. CELL CYCLE
- Nucleosome Structure and Function
- (2014) Robert K. McGinty et al. CHEMICAL REVIEWS
- First-in-Human Phase I Study of Pictilisib (GDC-0941), a Potent Pan-Class I Phosphatidylinositol-3-Kinase (PI3K) Inhibitor, in Patients with Advanced Solid Tumors
- (2014) D. Sarker et al. CLINICAL CANCER RESEARCH
- Cyclin-Dependent Kinase-2 as a Target for Cancer Therapy: Progress in the Development of CDK2 Inhibitors as Anti-Cancer Agents
- (2014) Tahir Chohan et al. CURRENT MEDICINAL CHEMISTRY
- Alternative end-joining pathway(s): Bricolage at DNA breaks
- (2014) Philippe Frit et al. DNA REPAIR
- Bloom syndrome
- (2014) Harleen Arora et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
- (2014) Mohammad Hojjat-Farsangi INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Excess centrosomes disrupt endothelial cell migration via centrosome scattering
- (2014) Erich J. Kushner et al. JOURNAL OF CELL BIOLOGY
- Discovery of a Selective, Substrate-Competitive Inhibitor of the Lysine Methyltransferase SETD8
- (2014) Anqi Ma et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma
- (2014) S. K. Knutson et al. MOLECULAR CANCER THERAPEUTICS
- Cyclin-Dependent Kinase Inhibitors as Marketed Anticancer Drugs: Where Are We Now? A Short Survey
- (2014) Gaëlle Mariaule et al. MOLECULES
- Synergistic blockade of mitotic exit by two chemical inhibitors of the APC/C
- (2014) Katharine L. Sackton et al. NATURE
- An update on PARP inhibitors—moving to the adjuvant setting
- (2014) Amir Sonnenblick et al. Nature Reviews Clinical Oncology
- Targeting bromodomains: epigenetic readers of lysine acetylation
- (2014) Panagis Filippakopoulos et al. NATURE REVIEWS DRUG DISCOVERY
- DNA-PK/Chk2 induces centrosome amplification during prolonged replication stress
- (2014) C-Y Wang et al. ONCOGENE
- Separate to operate: control of centrosome positioning and separation
- (2014) F. G. Agircan et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Causes and consequences of centrosome abnormalities in cancer
- (2014) S. A. Godinho et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- A Small Molecule Inhibitor of Human RAD51 Potentiates Breast Cancer Cell Killing by Therapeutic Agents in Mouse Xenografts
- (2014) Fei Huang et al. PLoS One
- CP-673451, a platelet-derived growth-factor receptor inhibitor, suppresses lung cancer cell proliferation and migration
- (2014) Yuling Xi et al. OncoTargets and Therapy
- Centrosome-declustering drugs mediate a two-pronged attack on interphase and mitosis in supercentrosomal cancer cells
- (2014) V Pannu et al. Cell Death & Disease
- Improved ataxia telangiectasia mutated kinase inhibitor KU60019 provides a promising treatment strategy for non-invasive breast cancer
- (2014) YING ZHU et al. Oncology Letters
- APC/C is an essential regulator of centrosome clustering
- (2014) Konstantinos Drosopoulos et al. Nature Communications
- Rational design and validation of a Tip60 histone acetyltransferase inhibitor
- (2014) Chunxia Gao et al. Scientific Reports
- Structure of Aurora B–INCENP in complex with barasertib reveals a potential transinhibitory mechanism
- (2014) Fabio Sessa et al. Acta Crystallographica Section F-Structural Biology Communications
- Suppression of Invasion and Metastasis of Triple-Negative Breast Cancer Lines by Pharmacological or Genetic Inhibition of Slug Activity
- (2014) Giovanna Ferrari-Amorotti et al. NEOPLASIA
- A Small-Molecule Inhibitor of RAD51 Reduces Homologous Recombination and Sensitizes Multiple Myeloma Cells to Doxorubicin
- (2014) David A. Alagpulinsa et al. Frontiers in Oncology
- Current clinical trials with polo-like kinase 1 inhibitors in solid tumors
- (2013) Hyungshin Yim ANTI-CANCER DRUGS
- Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
- (2013) S. R. Daigle et al. BLOOD
- DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin
- (2013) Wojciech M. Ciszewski et al. BREAST CANCER RESEARCH AND TREATMENT
- Chromatin Remodeling at DNA Double-Strand Breaks
- (2013) Brendan D. Price et al. CELL
- Targeting an Achilles’ heel of cancer with a WRN helicase inhibitor
- (2013) Monika Aggarwal et al. CELL CYCLE
- Acetylation dynamics of human nuclear proteins during the ionizing radiation-induced DNA damage response
- (2013) Martin Bennetzen et al. CELL CYCLE
- The BLM dissolvasome in DNA replication and repair
- (2013) Kelly A. Manthei et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- A Small Molecule Inhibitor of the BLM Helicase Modulates Chromosome Stability in Human Cells
- (2013) Giang Huong Nguyen et al. CHEMISTRY & BIOLOGY
- Design, Synthesis, and Biological Evaluation of an Allosteric Inhibitor of HSET that Targets Cancer Cells with Supernumerary Centrosomes
- (2013) Ciorsdaidh A. Watts et al. CHEMISTRY & BIOLOGY
- The Effect of Various Zinc Binding Groups on Inhibition of Histone Deacetylases 1-11
- (2013) Andreas S. Madsen et al. ChemMedChem
- Regulation of Autophosphorylation Controls PLK4 Self-Destruction and Centriole Number
- (2013) Inês Cunha-Ferreira et al. CURRENT BIOLOGY
- Supercoiling in DNA and chromatin
- (2013) Nick Gilbert et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia
- (2013) Jiewen Zhu et al. EMBO Molecular Medicine
- PARP inhibitors: polypharmacology versus selective inhibition
- (2013) Torun Ekblad et al. FEBS Journal
- Analysis of the Activities of RAD54, a SWI2/SNF2 Protein, Using a Specific Small-molecule Inhibitor
- (2013) Julianna S. Deakyne et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor
- (2013) Denise A. Yardley et al. JOURNAL OF CLINICAL ONCOLOGY
- Discovery of 4-{4-[(3R)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole (AZ20): A Potent and Selective Inhibitor of ATR Protein Kinase with Monotherapy in Vivo Antitumor Activity
- (2013) Kevin M. Foote et al. JOURNAL OF MEDICINAL CHEMISTRY
- Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and Rucaparib
- (2013) J. Murai et al. MOLECULAR CANCER THERAPEUTICS
- DNA Double-Strand Break Repair Pathway Choice Is Directed by Distinct MRE11 Nuclease Activities
- (2013) Atsushi Shibata et al. MOLECULAR CELL
- Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer
- (2013) Georgia Velimezi et al. NATURE CELL BIOLOGY
- Histone lysine demethylases as targets for anticancer therapy
- (2013) Jonas W. Højfeldt et al. NATURE REVIEWS DRUG DISCOVERY
- Regulation of nucleosome dynamics by histone modifications
- (2013) Gabriel E Zentner et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- DNA-PKcs Inhibition Sensitizes Cancer Cells to Carbon-Ion Irradiation via Telomere Capping Disruption
- (2013) Xin Zhou et al. PLoS One
- Catalytic Inhibitors of Topoisomerase II Differently Modulate the Toxicity of Anthracyclines in Cardiac and Cancer Cells
- (2013) Anna Vavrova et al. PLoS One
- Microhomology-mediated End Joining and Homologous Recombination share the initial end resection step to repair DNA double-strand breaks in mammalian cells
- (2013) L. N. Truong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Histone Modifications and DNA Double-Strand Break Repair after Exposure to Ionizing Radiations
- (2013) Clayton R. Hunt et al. RADIATION RESEARCH
- Drugging Topoisomerases: Lessons and Challenges
- (2012) Yves Pommier ACS Chemical Biology
- Epirubicin: Is it like doxorubicin in breast cancer? A clinical review
- (2012) Mustafa Khasraw et al. BREAST
- Inhibiting homologous recombination for cancer therapy
- (2012) Sophia B. Chernikova et al. CANCER BIOLOGY & THERAPY
- GF-15, a Novel Inhibitor of Centrosomal Clustering, Suppresses Tumor Cell Growth In Vitro and In Vivo
- (2012) M. S. Raab et al. CANCER RESEARCH
- Histone Lysine Methyltransferase SETD8 Promotes Carcinogenesis by Deregulating PCNA Expression
- (2012) M. Takawa et al. CANCER RESEARCH
- PARPs and the DNA damage response
- (2012) F. G. Sousa et al. CARCINOGENESIS
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- An Inhibitor of Nonhomologous End-Joining Abrogates Double-Strand Break Repair and Impedes Cancer Progression
- (2012) Mrinal Srivastava et al. CELL
- C-NAP1 and rootletin restrain DNA damage-induced centriole splitting and facilitate ciliogenesis
- (2012) Pauline C. Conroy et al. CELL CYCLE
- Molecular Pathways: The Complexity of the Epigenome in Cancer and Recent Clinical Advances
- (2012) M. Conte et al. CLINICAL CANCER RESEARCH
- 118 2-arylamino-6-ethynylpurines as Potent Irreversible Inhibitors of the Mitotic Kinase Nek2
- (2012) B. Carbain et al. EUROPEAN JOURNAL OF CANCER
- The centrosome as potential target for cancer therapy and prevention
- (2012) Nina Korzeniewski et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- A Clinical Overview of Centrosome Amplification in Human Cancers
- (2012) Jason Yongsheng Chan International Journal of Biological Sciences
- Breaking the ties that bind: New advances in centrosome biology
- (2012) Balca R. Mardin et al. JOURNAL OF CELL BIOLOGY
- US Food and Drug Administration Approval Overview in Metastatic Breast Cancer
- (2012) Patricia Cortazar et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of Homologous Recombination in Human Cells by Targeting RAD51 Recombinase
- (2012) Fei Huang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
- (2012) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Histone Lysine Methylation Dynamics: Establishment, Regulation, and Biological Impact
- (2012) Joshua C. Black et al. MOLECULAR CELL
- Recognition, signaling, and repair of DNA double-strand breaks produced by ionizing radiation in mammalian cells: The molecular choreography
- (2012) Larry H. Thompson MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- The DNA damage response and cancer therapy
- (2012) Christopher J. Lord et al. NATURE
- RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells
- (2012) Brian Budke et al. NUCLEIC ACIDS RESEARCH
- PARP activation regulates the RNA-binding protein NONO in the DNA damage response to DNA double-strand breaks
- (2012) Jana Krietsch et al. NUCLEIC ACIDS RESEARCH
- RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination
- (2012) B H Lok et al. ONCOGENE
- Nahuoic Acid A Produced by a Streptomyces sp. Isolated From a Marine Sediment Is a Selective SAM-Competitive Inhibitor of the Histone Methyltransferase SETD8
- (2012) David E. Williams et al. ORGANIC LETTERS
- Characterisation of a Tip60 Specific Inhibitor, NU9056, in Prostate Cancer
- (2012) Kelly Coffey et al. PLoS One
- The Centrosome in Cells and Organisms
- (2012) M. Bornens SCIENCE
- Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation
- (2012) E Fokas et al. Cell Death & Disease
- The interrelationship between APC/C and Plk1 activities in centriole disengagement
- (2012) T. Hatano et al. Biology Open
- Identification of Specific Inhibitors of Human RAD51 Recombinase Using High-Throughput Screening
- (2011) Fei Huang et al. ACS Chemical Biology
- Small Molecule Inhibitors of Histone Acetyltransferases as Epigenetic Tools and Drug Candidates
- (2011) Silviya D. Furdas et al. ARCHIV DER PHARMAZIE
- A drug targeting only p110α can block phosphoinositide 3-kinase signalling and tumour growth in certain cell types
- (2011) Stephen Jamieson et al. BIOCHEMICAL JOURNAL
- A phenanthrene derived PARP inhibitor is an extra-centrosomes de-clustering agent exclusively eradicating human cancer cells
- (2011) Asher Castiel et al. BMC CANCER
- Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines
- (2011) A Peasland et al. BRITISH JOURNAL OF CANCER
- Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
- (2011) Scott R. Daigle et al. CANCER CELL
- MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
- (2011) Kathrin M. Bernt et al. CANCER CELL
- Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination
- (2011) Michele Tavecchio et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Novel pathway of centrosome amplification that does not require DNA lesions
- (2011) Masataka Tsuda et al. CANCER SCIENCE
- SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis
- (2011) D Li et al. CELL DEATH AND DIFFERENTIATION
- Genz-644282, a Novel Non-Camptothecin Topoisomerase I Inhibitor for Cancer Treatment
- (2011) L. S. Kurtzberg et al. CLINICAL CANCER RESEARCH
- CPTH6, a Thiazole Derivative, Induces Histone Hypoacetylation and Apoptosis in Human Leukemia Cells
- (2011) D. Trisciuoglio et al. CLINICAL CANCER RESEARCH
- Iniparib Nonselectively Modifies Cysteine-Containing Proteins in Tumor Cells and Is Not a Bona Fide PARP Inhibitor
- (2011) X. Liu et al. CLINICAL CANCER RESEARCH
- Centrosome amplification in CHO and DT40 cells by inactivation of cyclin-dependent kinases
- (2011) Nathan Steere et al. Cytoskeleton
- 6-alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site
- (2011) Massimo Ghizzoni et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Update on aurora kinase targeted therapeutics in oncology
- (2011) Myke R Green et al. Expert Opinion on Drug Discovery
- Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications
- (2011) S. E. Polo et al. GENES & DEVELOPMENT
- HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications
- (2011) Omar Khan et al. IMMUNOLOGY AND CELL BIOLOGY
- Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma
- (2011) Karen M VanderMolen et al. JOURNAL OF ANTIBIOTICS
- Irreversible Nek2 Kinase Inhibitors with Cellular Activity
- (2011) Jeffrey C. Henise et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selective Inhibitors of Histone Methyltransferase DOT1L: Design, Synthesis, and Crystallographic Studies
- (2011) Yuan Yao et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Inhibition of Homologous Recombination by DNA-Dependent Protein Kinase Requires Kinase Activity, Is Titratable, and Is Modulated by Autophosphorylation
- (2011) J. A. Neal et al. MOLECULAR AND CELLULAR BIOLOGY
- A Peek into the Complex Realm of Histone Phosphorylation
- (2011) T. Banerjee et al. MOLECULAR AND CELLULAR BIOLOGY
- PF-04691502, a Potent and Selective Oral Inhibitor of PI3K and mTOR Kinases with Antitumor Activity
- (2011) J. Yuan et al. MOLECULAR CANCER THERAPEUTICS
- Centrosome clustering and chromosomal (in)stability: A matter of life and death
- (2011) Alwin Krämer et al. Molecular Oncology
- A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells
- (2011) Masoud Vedadi et al. Nature Chemical Biology
- The MRE11 complex: starting from the ends
- (2011) Travis H. Stracker et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- RECQL5 cooperates with Topoisomerase II alpha in DNA decatenation and cell cycle progression
- (2011) Mahesh Ramamoorthy et al. NUCLEIC ACIDS RESEARCH
- Two classes of BRC repeats in BRCA2 promote RAD51 nucleoprotein filament function by distinct mechanisms
- (2011) A. Carreira et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of helicase activity by a small molecule impairs Werner syndrome helicase (WRN) function in the cellular response to DNA damage or replication stress
- (2011) M. Aggarwal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide
- (2011) C.-C. Wu et al. SCIENCE
- Structural Basis of Substrate Methylation and Inhibition of SMYD2
- (2011) Andrew D. Ferguson et al. STRUCTURE
- Centrosomes and cilia in human disease
- (2011) Mónica Bettencourt-Dias et al. TRENDS IN GENETICS
- The RecQ DNA Helicases in DNA Repair
- (2010) Kara A. Bernstein et al. Annual Review of Genetics
- Synergistic antimicrotubule therapy for prostate cancer
- (2010) Vaishali Pannu et al. BIOCHEMICAL PHARMACOLOGY
- Targeting Mitotic Exit Leads to Tumor Regression In Vivo: Modulation by Cdk1, Mastl, and the PP2A/B55α,δ Phosphatase
- (2010) Eusebio Manchado et al. CANCER CELL
- The PI3K–Akt mediates oncogenic Met-induced centrosome amplification and chromosome instability
- (2010) Hyun-Ja Nam et al. CARCINOGENESIS
- APC/C-Cdh1
- (2010) Xinxian Qiao et al. CELL CYCLE
- A novel microtubule-modulating noscapinoid triggers apoptosis by inducing spindle multipolarity via centrosome amplification and declustering
- (2010) P Karna et al. CELL DEATH AND DIFFERENTIATION
- Centriole Reduplication during Prolonged Interphase Requires Procentriole Maturation Governed by Plk1
- (2010) Jadranka Lončarek et al. CURRENT BIOLOGY
- Rad54, the motor of homologous recombination
- (2010) Alexander V. Mazin et al. DNA REPAIR
- Inside HDAC with HDAC inhibitors
- (2010) Philippe Bertrand EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Aurora kinase inhibitors: novel small molecules with promising activity in acute myeloid and Philadelphia-positive leukemias
- (2010) A S Moore et al. LEUKEMIA
- In vivo efficacy of griseofulvin against multiple myeloma
- (2010) Young Kim et al. LEUKEMIA RESEARCH
- ENMD-2076 Is an Orally Active Kinase Inhibitor with Antiangiogenic and Antiproliferative Mechanisms of Action
- (2010) G. C. Fletcher et al. MOLECULAR CANCER THERAPEUTICS
- PF-03814735, an Orally Bioavailable Small Molecule Aurora Kinase Inhibitor for Cancer Therapy
- (2010) Jitesh P. Jani et al. MOLECULAR CANCER THERAPEUTICS
- Hydroxyurea-Stalled Replication Forks Become Progressively Inactivated and Require Two Different RAD51-Mediated Pathways for Restart and Repair
- (2010) Eva Petermann et al. MOLECULAR CELL
- Genomic instability — an evolving hallmark of cancer
- (2010) Simona Negrini et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A critical role of integrin-linked kinase, ch-TOG and TACC3 in centrosome clustering in cancer cells
- (2010) A B Fielding et al. ONCOGENE
- MCPH1/BRIT1 limits ionizing radiation-induced centrosome amplification
- (2010) J A L Brown et al. ONCOGENE
- Rad52 inactivation is synthetically lethal with BRCA2 deficiency
- (2010) Z. Feng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Polo-like kinase 4: the odd one out of the family
- (2010) James E Sillibourne et al. Cell Division
- Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy
- (2010) Julia M. Wagner et al. Clinical Epigenetics
- DNA ligase IV as a new molecular target for temozolomide
- (2009) Natsuko Kondo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia
- (2009) Rong Chen et al. BLOOD
- KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR/ABL translocation
- (2009) Y. Shiotsu et al. BLOOD
- A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells
- (2009) Andrew J. Massey et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Development of the pan-DAC inhibitor panobinostat (LBH589): Successes and challenges
- (2009) Peter Atadja CANCER LETTERS
- Epigallocatechin-3-Gallate, a Histone Acetyltransferase Inhibitor, Inhibits EBV-Induced B Lymphocyte Transformation via Suppression of RelA Acetylation
- (2009) K.-C. Choi et al. CANCER RESEARCH
- Overexpression and Mislocalization of the Chromosomal Segregation Protein Separase in Multiple Human Cancers
- (2009) R. Meyer et al. CLINICAL CANCER RESEARCH
- Polo Kinase and Separase Regulate the Mitotic Licensing of Centriole Duplication in Human Cells
- (2009) Meng-Fu Bryan Tsou et al. DEVELOPMENTAL CELL
- A histone code for the DNA damage response in mammalian cells?
- (2009) Armelle Corpet et al. EMBO JOURNAL
- Centriole separation in DNA damage-induced centrosome amplification
- (2009) Chiara Saladino et al. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
- Inhibition of Lysine Acetyltransferase KAT3B/p300 Activity by a Naturally Occurring Hydroxynaphthoquinone, Plumbagin
- (2009) Kodihalli C. Ravindra et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The SCFSlimbubiquitin ligase regulates Plk4/Sak levels to block centriole reduplication
- (2009) Gregory C. Rogers et al. JOURNAL OF CELL BIOLOGY
- -Tubulin-containing abnormal centrioles are induced by insufficient Plk4 in human HCT116 colorectal cancer cells
- (2009) R. Kuriyama et al. JOURNAL OF CELL SCIENCE
- Mesenchymal Stem Cells Derived from Dental Tissues vs. Those from Other Sources: Their Biology and Role in Regenerative Medicine
- (2009) G.T.-J. Huang et al. JOURNAL OF DENTAL RESEARCH
- Synthesis and Structure−Activity Relationship of Griseofulvin Analogues as Inhibitors of Centrosomal Clustering in Cancer Cells
- (2009) Mads H. Rønnest et al. JOURNAL OF MEDICINAL CHEMISTRY
- Functional Dynamics of Polo-Like Kinase 1 at the Centrosome
- (2009) K. Kishi et al. MOLECULAR AND CELLULAR BIOLOGY
- The indenoisoquinoline noncamptothecin topoisomerase I inhibitors: update and perspectives
- (2009) Y. Pommier et al. MOLECULAR CANCER THERAPEUTICS
- Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion
- (2009) S. E. Golding et al. MOLECULAR CANCER THERAPEUTICS
- Nucleosome positioning and gene regulation: advances through genomics
- (2009) Cizhong Jiang et al. NATURE REVIEWS GENETICS
- Role of Mre11 in chromosomal nonhomologous end joining in mammalian cells
- (2009) Emilie Rass et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Inhibition of ATR protein kinase activity by schisandrin B in DNA damage response
- (2009) H. Nishida et al. NUCLEIC ACIDS RESEARCH
- DNA damage induces Chk1-dependent threonine-160 phosphorylation and activation of Cdk2
- (2009) E Bourke et al. ONCOGENE
- Centrosome function in cancer: guilty or innocent?
- (2009) Deborah Zyss et al. TRENDS IN CELL BIOLOGY
- Bisubstrate Inhibitors of the MYST HATs Esa1 and Tip60
- (2008) Jiang Wu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Transient Inhibition of ATM Kinase Is Sufficient to Enhance Cellular Sensitivity to Ionizing Radiation
- (2008) M. D. Rainey et al. CANCER RESEARCH
- Homologous recombination in DNA repair and DNA damage tolerance
- (2008) Xuan Li et al. CELL RESEARCH
- Targeting the Kinesin Spindle Protein: Basic Principles and Clinical Implications
- (2008) V. Sarli et al. CLINICAL CANCER RESEARCH
- The consequences of Rad51 overexpression for normal and tumor cells
- (2008) Hannah L. Klein DNA REPAIR
- Comparison of nonhomologous end joining and homologous recombination in human cells
- (2008) Z MAO et al. DNA REPAIR
- Epi-drugs to fight cancer: From chemistry to cancer treatment, the road ahead
- (2008) Antonello Mai et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Resistance to therapy caused by intragenic deletion in BRCA2
- (2008) Stacey L. Edwards et al. NATURE
- A forward chemical genetic screen reveals an inhibitor of the Mre11–Rad50–Nbs1 complex
- (2008) Aude Dupré et al. Nature Chemical Biology
- Genome instability: a mechanistic view of its causes and consequences
- (2008) Andrés Aguilera et al. NATURE REVIEWS GENETICS
- Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer
- (2008) Martin F. Lavin NATURE REVIEWS MOLECULAR CELL BIOLOGY
- PI3K pathway alterations in cancer: variations on a theme
- (2008) T L Yuan et al. ONCOGENE
- A chemical compound that stimulates the human homologous recombination protein RAD51
- (2008) K. Jayathilaka et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MMEJ repair of double-strand breaks (director’s cut): deleted sequences and alternative endings
- (2008) Mitch McVey et al. TRENDS IN GENETICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started